| ○ |
| 上田 龍三 |
愛知医科大学医学部教授 |
| 腫瘍内科学 |
Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, Saburi Y, Miyamoto T, Takemoto S, Suzushima H, Tsukasaki K, Nosaka K, Fujiwara H, Ishitsuka K, Inagaki H, Ogura M, Akinaga S, Tomonaga M, Tobinai K, Ueda R. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study.
J Clin Oncol. 2012 Mar 10;30(8):837-42. （Epub 2012 Feb 6） |
Nishikawa H, Maeda Y, Ishida T, Gnjatic S, Sato E, Mori F, Sugiyama D, Ito A, Fukumori Y, Utsunomiya A, Inagaki H, Old LJ, Ueda R, Sakaguchi S. Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma Blood. 2012 Mar 29;119(13):3097-104.
( Epub 2012 Feb 8) |
Masaki A, Ishida T, Suzuki S, Ito A, Mori F, Sato F, Narita T, Yamada T, Ri M, Kusumoto S, Komatsu H, Tanaka Y, Niimi A, Inagaki H, Iida S, Ueda R. Autologous Tax-Specific CTL Therapy in a Primary Adult T Cell Leukemia/Lymphoma Cell-Bearing NOD/Shi-scid, IL-2Rγnull Mouse Model
J Immunol. 2013 Jul 1;191(1):135-44. （Epub 2013 Jun 3） |
|
| |
| 加藤 治文 |
医療法人社団武蔵野会新座志木中央総合病院
名誉院長 |
| 胸部外科、呼吸器外科 |
A Randomized Trials of Adjuvant Chemotherapy with Uracil-Tegafur for Adenocarcinoma of the Lung. Kato H, Ichinose Y, Ohta M, et al. N Engl J Med
USA, 2004 April 350: 1713-1721 |
| Development for a growing Japanese patient population: Facilitating new technologies for future health care. Kato H, Nishimura T, Ikeda N, et al. J Proteomics Netherlands, 2011 74:759-764 |
「臨床プロテオミクス−バイオマーカー探索から個別化医療へ」編集：日本プロテオーム研究会 編集代表：中村和行、西尾和人、西村俊秀 監修：加藤治文
金原出版 （2012） |
|
| |
| 澁谷 正史 |
学校法人学文館上武大学 副学長 |
| 分子生物学、血管生物学 |
| Nucleotide Sequence of Fujinami Sarcoma Virus : Evolutionary Relationship of its Transforming Gene with Transforming Genes of Other Sarcoma Viruses. Shibuya M, Hanafusa H. Cell, 30, 787-795, 1982. |
| A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-g and DNA synthesis in vascular endothelial cells. Takahashi T, Yamaguchi S, Chida K, Shibuya M. EMBO J. 20, 2768-2778, 2001. |
| Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Shibuya M, Claesson-Welsh L. Exp Cell Res. 312, 549-560, 2006.（総説、査読なし. 2006-2011に本誌としてトップクラスで引用され、表彰された。） |
|
| |
| 新海 哲 |
独立行政法人国立病院機構四国がんセンター
院長 |
| 臨床腫瘍学 |
| Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy. Shinkai, T., Saijo, N., Tominaga, K., Eguchi, K., Shimizu, E., Sasaki, Y., Fujita, F., Futami, H., Ohkura, O. Suemasu, K. Cancer 1986 57:1318-1323. |
| Cytogenetic effect of carboplatin on human lymphocytes. Shinkai, T., Saijo, N., Eguchi, K., Sasaki, Y., Tamura, T., Sakurai, M., Suga, J., Nakano, H., Nakagawa, K., Hong, WS. Nakajima, T. Cancer Chemother Pharmacol 1988 21:203-207. |
| Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer. Shinkai, T., Arioka, H., Kunikane, H., Eguchi, K., Sasaki, Y., Tamura, T., Ohe, Y., Oshita, F., Nishio, M., Karato, A., Okamoto, H., Nakashima, H., Ohmatsu, H., Shiraishi, J., Nomura, N. and Saijo, N. Cancer Res 1994 54:2636-2642. |
|
| |
| 田島 和雄 |
愛知県がんセンター研究所 所長 |
| 疫学、予防医学 |
がん予防の最前線、上巻「基礎知識から新戦略へ」、下巻「最新の研究成果と予防戦略」、田島和雄監修、著者（各巻各１編）
昭和堂（上巻：2004、下巻：2005） |
＜特許＞
脂肪酸測定のための方法およびシステム
番号：4359661、田島和雄、栗木清典
2009年8月21日取得 |
| Ethnoepidemiology of Asian cancer epidemic pattern and its prevention strategy (Plenary Lecture), Kazuo Tajima, Asian Pacific Cancer Conference, 2011 |
|
| |
| 中釜 斉 |
独立行政法人国立がん研究センター研究所 所長 |
| 分子腫瘍学、翻訳制御機構の異常と消化器発がん、環境発がん、比較ゲノミクス |
| Okamoto K, Ishiguro T, Midorikawa Y, Ohata H, Izumiya M, Tsuchiya T, Sato A, Sakai H, and Nakagama H. miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver. EMBO J, 31(7):1752-63, 2012 |
| Tsuchiya N, Izumiya M, Ogata-Kawata H, Okamoto K, Fujiwara Y, Nakai M, Okabe A, Schetter AJ, Bowman ED, Midorikawa Y, Sugiyama Y, Aburatani H, Harris CC, Nakagama H. Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-transcriptional Regulation of p21. Cancer Res, 71(13):4628-4639, 2011 |
| Tazawa H, Tsuchiya N, Izumiya M and Nakagama H. Tumor suppressive miR-34a induces senescence-like growth arrest through modulation of E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA, 104:15472-15477, 2007. |
|
| |
| 平岡 眞寛 |
京都大学大学院医学研究科
放射線腫瘍学・画像応用治療学 教授 |
| 放射線腫瘍学 |
| Intrafractional tracking accuracy in infrared marker-based hybrid dynamic tumour-tracking irradiation with a gimballed linac. Mukumoto N, Nakamura M, Yamada M, Takahashi K, Tanabe H, Yano S, Miyabe Y, Ueki N, Kaneko S, Matsuo Y, Mizowaki T, Sawada A, Kokubo M, Hiraoka M. Radiother Oncol. 2014 May;111(2):301-5. doi: 10.1016/j.radonc.2014.02.018. |
| Geometric and dosimetric accuracy of dynamic tumor-tracking conformal arc irradiation with a gimbaled x-ray head. Ono T, Miyabe Y, Yamada M, Shiinoki T, Sawada A, Kaneko S, Monzen H, Mizowaki T, Kokubo M, Hiraoka M. Med Phys. 2014 Mar;41(3):031705. doi: 10.1118/1.4864242. |
| Intra- and interfractional variations in geometric arrangement between lung tumours and implanted markers. Ueki N, Matsuo Y, Nakamura M, Mukumoto N, Iizuka Y, Miyabe Y, Sawada A, Mizowaki T, Kokubo M, Hiraoka M. Radiother Oncol. 2014 Mar;110(3):523-8. doi: 10.1016/j.radonc.2014.01.014. |
|
| |
| 前原 喜彦 |
九州大学大学院消化器・総合外科 教授 |
| 消化器（消化管、肝・胆・膵、脾・門脈）移植 肺 乳腺 血管 |
Colorectal cancer screening with odour material by canine scent detection.
Sonoda H, Kohnoe S, Yamazato T, Satoh Y, Morizono G, Shikata K, Morita M, Watanabe A, Morita M, Kakeji Y, Inoue F, Maehara Y. GUT 60(6):814-819,2011 |
Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations.
Saeki H, Kitao H, Yoshinaga K, Nakanoko T, Kubo N, Kakeji Y, Morita M, Maehara Y Clin Cancer Res 17(7):1731-1740,2011 |
Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway.
Takeishi K, Taketomi A, Shirabe K, Toshima T, Motomura T, Ikegami T, Yoshizumi T, Sakane F, Maehara Y. J Hepatol 57(1):77-83,2012 |
|
